• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖宫产瘢痕妊娠子宫胎盘循环的发展:一项病例对照研究。

Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study.

作者信息

Jauniaux Eric, Zosmer Nurit, De Braud Lucrezia V, Ashoor Ghalia, Ross Jackie, Jurkovic Davor

机构信息

EGA Institute for Women's Health, University College London, London, United Kingdom; Faculty of Population Health Sciences, University College London, London, United Kingdom.

Early Pregnancy and Gynaecology Assessment Unit, King's College Hospital, London, United Kingdom.

出版信息

Am J Obstet Gynecol. 2022 Mar;226(3):399.e1-399.e10. doi: 10.1016/j.ajog.2021.08.056. Epub 2021 Sep 4.

DOI:10.1016/j.ajog.2021.08.056
PMID:34492222
Abstract

BACKGROUND

Cesarean scar pregnancies carry a high risk of pregnancy complications including placenta previa with antepartum hemorrhage, placenta accreta spectrum, and uterine rupture.

OBJECTIVE

To evaluate the development of utero-placental circulation in the first half of pregnancy in ongoing cesarean scar pregnancies and compare it with pregnancies implanted in the lower uterine segment above a previous cesarean delivery scar with no evidence of placenta accreta spectrum at delivery STUDY DESIGN: This was a retrospective case-control study conducted in 2 tertiary referral centers. The study group included 27 women who were diagnosed with a live cesarean scar pregnancy in the first trimester of pregnancy and who elected to conservative management. The control group included 27 women diagnosed with an anterior low-lying placenta or placenta previa at 19 to 22 weeks of gestation who had first and early second trimester ultrasound examinations. In both groups, the first ultrasound examination was carried out at 6 to 10 weeks to establish the pregnancy location, viability, and to confirm the gestational age. The utero-placental and intraplacental vasculatures were examined using color Doppler imaging and were described semiquantitatively using a score of 1 to 4. The remaining myometrial thickness was recorded in the study group, whereas the ultrasound features of a previous cesarean delivery scar including the presence of a niche were noted in the controls. Both the cesarean scar pregnancies and the controls had ultrasound examinations at 11 to 14 and 19 to 22 weeks of gestation.

RESULTS

The mean color Doppler imaging vascularity score in the ultrasound examination at 6 to 10 weeks was significantly (P<.001) higher in the cesarean scar pregnancy group than in the controls. High vascularity scores of 3 and 4 were recorded in 20 of 27 (74%) cases of the cesarean scar pregnancy group. There was no vascularity score of 4, and only 3 of 27 (11%) controls had a vascularity score of 3. In 15 of the 27 (55.6%) cesarean scar pregnancies, the residual myometrial thickness was <2 mm. In the ultrasound examination at 11 to 14 weeks, there was no significant difference between the groups in the number of cases with an increased subplacental vascularity. However, 12 cesarean scar pregnancies (44%) presented with 1 or more placental lacunae whereas there was no case with lacunae in the controls. Of the 18 cesarean scar pregnancies that progressed into the third trimester, 10 of them were diagnosed with placenta previa accreta at birth, including 4 creta and 6 increta. In the 19 to 22 weeks ultrasound examination, 8 of the 10 placenta accreta spectrum patients presented with subplacental hypervascularity, out of which 6 showed placental lacunae.

CONCLUSION

The vascular changes in the utero-placental and intervillous circulations in cesarean scar pregnancies are due to the loss of the normal uterine structure in the scar area and the development of placental tissue in proximity of large diameter arteries of the outer uterine wall. The intensity of these vascular changes, the development of placenta accreta spectrum, and the risk of uterine rupture are probably related to the residual myometrial thickness of the scar defect at the start of pregnancy. A better understanding of the pathophysiology of the utero-placental vascular changes associated with cesarean scar pregnancies should help in identifying those cases that may develop major complications. It will contribute to providing counseling for women about the risks associated with different management strategies.

摘要

背景

剖宫产瘢痕妊娠会带来较高的妊娠并发症风险,包括前置胎盘伴产前出血、胎盘植入谱系疾病和子宫破裂。

目的

评估持续存在的剖宫产瘢痕妊娠在妊娠前半期子宫胎盘循环的发育情况,并将其与植入于既往剖宫产瘢痕上方子宫下段且分娩时无胎盘植入谱系证据的妊娠进行比较。

研究设计

这是一项在2个三级转诊中心进行的回顾性病例对照研究。研究组包括27名在妊娠早期被诊断为存活的剖宫产瘢痕妊娠且选择保守治疗的女性。对照组包括27名在妊娠19至22周时被诊断为前置胎盘或低置胎盘且在孕早期和孕中期进行了超声检查的女性。两组均在6至10周时进行首次超声检查,以确定妊娠位置、存活情况并确认孕周。使用彩色多普勒成像检查子宫胎盘和胎盘内血管,并采用1至4分进行半定量描述。研究组记录剩余肌层厚度,而对照组记录既往剖宫产瘢痕的超声特征,包括憩室的存在情况。剖宫产瘢痕妊娠组和对照组均在妊娠11至14周以及19至22周时进行超声检查。

结果

剖宫产瘢痕妊娠组在6至10周超声检查时的平均彩色多普勒成像血管评分显著高于对照组(P<0.001)。剖宫产瘢痕妊娠组27例中有20例(74%)记录到血管评分3分和4分。对照组无血管评分为4分的情况,仅有27例中的3例(11%)血管评分为3分。27例剖宫产瘢痕妊娠中有15例(55.6%)剩余肌层厚度<2 mm。在11至14周的超声检查中,两组胎盘下血管增多的病例数无显著差异。然而,12例剖宫产瘢痕妊娠(44%)出现1个或更多胎盘腔隙,而对照组无出现腔隙的病例。在进展至妊娠晚期的18例剖宫产瘢痕妊娠中,有10例在出生时被诊断为前置胎盘植入,包括4例胎盘植入和6例胎盘植入穿透。在19至22周的超声检查中,10例胎盘植入谱系疾病患者中有8例出现胎盘下血管增多,其中6例出现胎盘腔隙。

结论

剖宫产瘢痕妊娠中子宫胎盘和绒毛间隙循环的血管变化是由于瘢痕区域正常子宫结构的丧失以及胎盘组织在外子宫壁大直径动脉附近的发育。这些血管变化的强度、胎盘植入谱系疾病的发生以及子宫破裂的风险可能与妊娠开始时瘢痕缺损处的剩余肌层厚度有关。更好地理解与剖宫产瘢痕妊娠相关的子宫胎盘血管变化的病理生理学,应有助于识别那些可能发生严重并发症的病例。这将有助于为女性提供关于不同管理策略相关风险的咨询。

相似文献

1
Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study.剖宫产瘢痕妊娠子宫胎盘循环的发展:一项病例对照研究。
Am J Obstet Gynecol. 2022 Mar;226(3):399.e1-399.e10. doi: 10.1016/j.ajog.2021.08.056. Epub 2021 Sep 4.
2
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.前瞻性评估剖宫产术后子宫瘢痕对胎盘植入谱系疾病围产期诊断的影响。
Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8.
3
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.中孕期超声在前置胎盘孕妇胎盘植入谱系疾病产前诊断中的应用:来自 ADoPAD 研究的结果。
Ultrasound Obstet Gynecol. 2022 Sep;60(3):381-389. doi: 10.1002/uog.24889.
4
Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface.胎盘植入部位的胎盘剥离失败与胎盘界面的纤维蛋白样物质过度沉积有关。
Am J Obstet Gynecol. 2022 Feb;226(2):243.e1-243.e10. doi: 10.1016/j.ajog.2021.08.026. Epub 2021 Aug 28.
5
The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.经阴道超声在胎盘植入谱系疾病高危产妇分娩前评估中的作用。
Am J Obstet Gynecol. 2023 Oct;229(4):445.e1-445.e11. doi: 10.1016/j.ajog.2023.05.004. Epub 2023 May 13.
6
The clinical outcome of cesarean scar pregnancies implanted "on the scar" versus "in the niche".剖宫产瘢痕妊娠“着床于瘢痕”与“着床于憩室”的临床结局
Am J Obstet Gynecol. 2017 May;216(5):510.e1-510.e6. doi: 10.1016/j.ajog.2017.01.019. Epub 2017 Jan 20.
7
First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy.早孕期低着床部位胎盘植入谱系疾病的超声诊断特征。
Ultrasound Obstet Gynecol. 2022 Apr;59(4):457-464. doi: 10.1002/uog.24828. Epub 2022 Mar 10.
8
Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean delivery.在前置胎盘且有剖宫产史的妇女中,利用超声进行侵袭性胎盘的产前诊断。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:97-103. doi: 10.1016/j.ejogrb.2024.08.035. Epub 2024 Aug 28.
9
Lower uterine segment scar assessment at 11-14 weeks' gestation to screen for placenta accreta spectrum in women with prior Cesarean delivery.在有剖宫产史的孕妇中,于 11-14 孕周时行子宫下段评估以筛查胎盘部位滋养细胞肿瘤谱。
Ultrasound Obstet Gynecol. 2022 Jan;59(1):40-48. doi: 10.1002/uog.23734.
10
Evaluation of preoperative ultrasound signs associated with bladder injury during complex Cesarean delivery: case-control study.评估复杂剖宫产术中与膀胱损伤相关的术前超声征象:病例对照研究。
Ultrasound Obstet Gynecol. 2024 Jun;63(6):781-788. doi: 10.1002/uog.27590. Epub 2024 May 10.

引用本文的文献

1
Identifying fibroblast-derived sFRP2 as a therapeutic target and engineering siRNA therapy for uterine scarring.确定成纤维细胞衍生的sFRP2作为治疗靶点并设计针对子宫瘢痕的RNA干扰疗法。
Nat Commun. 2025 Jul 25;16(1):6850. doi: 10.1038/s41467-025-62248-1.
2
A scoring system predicts the adverse outcomes for cesarean scar pregnancy treated with transvaginal hysterotomy.一种评分系统可预测经阴道子宫切开术治疗剖宫产瘢痕妊娠的不良结局。
Quant Imaging Med Surg. 2025 Jun 6;15(6):5086-5100. doi: 10.21037/qims-24-1337. Epub 2025 Jun 3.
3
Placenta accreta spectrum.
胎盘植入谱系疾病
Nat Rev Dis Primers. 2025 Jun 5;11(1):40. doi: 10.1038/s41572-025-00624-3.
4
A Possible Role of Clinical Factors in Choosing the Best Treatment Modality in Cesarean Scar Pregnancy.临床因素在剖宫产瘢痕妊娠最佳治疗方式选择中的可能作用
Diagnostics (Basel). 2025 Apr 10;15(8):965. doi: 10.3390/diagnostics15080965.
5
Biology and Pathophysiology of Placenta Accreta Spectrum Disorder.胎盘植入谱系障碍的生物学与病理生理学
Obstet Gynecol. 2025 Jun 1;145(6):611-620. doi: 10.1097/AOG.0000000000005903. Epub 2025 Apr 10.
6
Successful management of cesarean scar pregnancy progressive to placenta accreta spectrum: An uncommon condition in Vietnam and mini-review of the literature.剖宫产瘢痕妊娠进展为胎盘植入谱系疾病的成功管理:越南的一种罕见情况及文献综述
Int J Surg Case Rep. 2025 Mar;128:111076. doi: 10.1016/j.ijscr.2025.111076. Epub 2025 Feb 25.
7
Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine-scar dehiscence.探索病理生理学见解以提高超声标志物在鉴别胎盘植入谱系疾病与子宫瘢痕裂开方面的诊断效用。
Ultrasound Obstet Gynecol. 2025 Jan;65(1):85-93. doi: 10.1002/uog.29144. Epub 2024 Dec 15.
8
Abnormal Placentation After Caesarean Section: A Retrospective Study.剖宫产术后胎盘异常:一项回顾性研究。
Cureus. 2024 Aug 20;16(8):e67316. doi: 10.7759/cureus.67316. eCollection 2024 Aug.
9
Obstetric outcomes in the expectant management of cesarean scar pregnancy with fetal heart activity: a single-center retrospective cohort study.胎儿有心跳的剖宫产瘢痕妊娠期待治疗的产科结局:一项单中心回顾性队列研究
Quant Imaging Med Surg. 2024 Sep 1;14(9):6590-6600. doi: 10.21037/qims-24-500. Epub 2024 Aug 22.
10
Evaluation of maternal serum protein biomarkers in the prenatal evaluation of placenta accreta spectrum: A systematic scoping review.胎盘植入谱系产前评估中母体血清蛋白生物标志物的评估:一项系统综述。
Acta Obstet Gynecol Scand. 2024 Dec;103(12):2335-2347. doi: 10.1111/aogs.14918. Epub 2024 Jul 14.